Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
SEC priorities for asset management industry
David Tittsworth, Ropes & Gray investment management counsel, examines what’s changed for the asset management industry under the Trump administration and what to expect during 2018.
Enforcement of electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, addresses an emerging trend in the electronic health records space, where a number of companies are being investigated under the False Claims Act.
Impact of tax reform on charitable giving
Cameron Casey, Ropes & Gray private client group partner, examines the various reforms included in the Tax Cuts and Jobs Act (TCJA) and how they may affect the federal tax benefits of charitable giving.
Impact of changes at the PTAB on patent owners
Scott McKeown, Ropes & Gray IP litigation partner and chair of the firm’s Patent Trial and Appeal Board (PTAB) group, examines how some recent changes at the PTAB will benefit patent owners.
Anti-corruption & international risk developments
Alex Rene, co-chair of Ropes & Gray’s anti-corruption / international risk practice and managing partner of the firm’s Washington, D.C. office, discusses recent FCPA enforcement activity as well as international risks facing companies.
Impact of environmental, social and governance agenda on tax
Andrew Howard, Ropes & Gray tax partner, addresses tax coming out of the shadows and becoming part of an environmental, social and governance (ESG) agenda.